<h1>In-house R&D facility approval framework under income tax law requires DSIR cooperation, audit compliance, and ongoing reporting.</h1> FORM 11 sets out the statutory application and agreement framework for approval of in-house research and development facilities under section 45(2) of the Income-tax Act, 2025, read with Rule 29. It applies to eligible companies maintaining or proposing to maintain an in-house R&D facility and requires disclosure of company particulars, a DSIR agreement, and binding undertakings on audit, reporting, asset use, and compliance. Approval is facility-specific and remains subject to continued compliance, with DSIR serving as the prescribed authority for evaluation and oversight.